148 related articles for article (PubMed ID: 20379095)
1. [Successful rituximab monotherapy in a patient with mucosa-associated lymphoid tissue lymphoma of the rectum with trisomy 3, 18].
Kagawa M; Okamura S; Okamoto K; Kitamura S; Kimura T; Niki M; Kaji M; Okahisa T; Yano M; Kagawa S; Kudo E; Sano T; Imoto Y; Wada S; Takayama T
Nihon Shokakibyo Gakkai Zasshi; 2010 Apr; 107(4):612-9. PubMed ID: 20379095
[TBL] [Abstract][Full Text] [Related]
2. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.
Raderer M; Jäger G; Brugger S; Püspök A; Fiebiger W; Drach J; Wotherspoon A; Chott A
Oncology; 2003; 65(4):306-10. PubMed ID: 14707449
[TBL] [Abstract][Full Text] [Related]
3. Rituximab-induced remission of a gastric MALT lymphoma.
Datta YH; Kampalath B; Binion DG
Leuk Lymphoma; 2004 Jun; 45(6):1297-9. PubMed ID: 15360017
[TBL] [Abstract][Full Text] [Related]
4. Chronic autoimmune thyroiditis (Hashimoto's thyroiditis) in patients with MALT lymphoma.
Troch M; Woehrer S; Streubel B; Weissel M; Hoffmann M; Müllauer L; Chott A; Raderer M
Ann Oncol; 2008 Jul; 19(7):1336-1339. PubMed ID: 18334510
[TBL] [Abstract][Full Text] [Related]
5. Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma.
Okamura I; Imai H; Mori K; Ogura K; Isoda A; Mihara K; Matsumoto M; Saito R; Takahashi T; Ikeda T
Int J Hematol; 2015 Jan; 101(1):46-51. PubMed ID: 25378228
[TBL] [Abstract][Full Text] [Related]
6. Treatment of localized oral MALT lymphoma by rituximab: a case report.
Yamagata K; Onizawa K; Kojima H; Yoshida H
Oral Maxillofac Surg; 2008 Dec; 12(4):227-30. PubMed ID: 18830723
[TBL] [Abstract][Full Text] [Related]
7. t(11;18)(q21;q21)-positive advanced-stage MALT lymphoma associated with monoclonal gammopathy: resistance to rituximab or rituximab-containing chemotherapy.
Ohno H; Isoda K
J Clin Exp Hematop; 2008 Nov; 48(2):47-54. PubMed ID: 19039196
[TBL] [Abstract][Full Text] [Related]
8. [Regression of primary rectal MALT lymphoma after Helicobacter pylori eradication].
Nosaka K; Shono T; Yonemura Y; Iyama K; Sasaki Y; Endo S; Okuno Y; Mitsuya H
Rinsho Ketsueki; 2014 Aug; 55(8):948-52. PubMed ID: 25186484
[TBL] [Abstract][Full Text] [Related]
9. Rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomised observational study.
Amiot A; Lévy M; Copie-Bergman C; Dupuis J; Szablewski V; Le Baleur Y; Baia M; Belhadj K; Sobhani I; Leroy K; Haioun C; Delchier JC
Aliment Pharmacol Ther; 2014 Mar; 39(6):619-28. PubMed ID: 24467480
[TBL] [Abstract][Full Text] [Related]
10. [Endoscopic ultrasound (EUS) in initial assessment and follow-up of patients with MALT lymphoma treated drug therapy].
Pavlović AR; Krstić M; Tomić D; Bjelović M; Jesić R; Suvajdzić N
Acta Chir Iugosl; 2005; 52(1):83-9. PubMed ID: 16119319
[TBL] [Abstract][Full Text] [Related]
11. Multifocal extranodal mucosa-associated lymphoid tissue lymphoma affecting the larynx.
Arndt S; Veelken H; Schmitt-Gräff A; Aschendorff A; Maier W; Richter B
Ann Otol Rhinol Laryngol; 2007 Apr; 116(4):257-61. PubMed ID: 17491523
[TBL] [Abstract][Full Text] [Related]
12. The Progression of Esophageal Mucosa-associated Lymphoid Tissue Lymphoma after Helicobacter pylori Eradication Therapy: A Case Report and Discussion of Therapeutic Options.
Takeuchi Y; Miyahara K; Morito T; Okikawa Y; Kinugasa H; Moritou Y; Higashi R; Kunihiro M; Nakagawa M
Intern Med; 2019 Jan; 58(2):207-212. PubMed ID: 30146577
[TBL] [Abstract][Full Text] [Related]
13. [Regression of MALT lymphoma of the rectum after Helicobacter pylori eradication therapy in a patient negative for Helicobacter pylori].
Nomura E; Uchimi K; Abue M; Kon H; Noguchi T; Suzuki S; Suzuki M; Onodera H; Tateno H; Ota Y
Nihon Shokakibyo Gakkai Zasshi; 2010 Sep; 107(9):1466-73. PubMed ID: 20827043
[TBL] [Abstract][Full Text] [Related]
14. Mucosa-associated lymphoid tissue (MALT) lymphoma of the rectum with chromosomal translocation of the t(11;18)(q21;q21) and an additional aberration of trisomy 3.
Hosaka S; Akamatsu T; Nakamura S; Kaneko T; Kitano K; Kiyosawa K; Ota H; Hosaka N; Miyabayashi H; Katsuyama T
Am J Gastroenterol; 1999 Jul; 94(7):1951-4. PubMed ID: 10406266
[TBL] [Abstract][Full Text] [Related]
15. [Mucosa-associated lymphoid tissue (MALT) lymphoma of the lung treated by surgery and rituximab; report of a case].
Yoshida C; Tarumi S; Kato A; Nii K; Chang SS; Yokomise H
Kyobu Geka; 2013 Feb; 66(2):169-72. PubMed ID: 23381369
[TBL] [Abstract][Full Text] [Related]
16. A pilot phase II study of ofatumumab monotherapy for extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma.
Kiesewetter B; Neuper O; Mayerhoefer ME; Dolak W; Lukas J; Simonitsch-Klupp I; Raderer M
Hematol Oncol; 2018 Feb; 36(1):49-55. PubMed ID: 28695630
[TBL] [Abstract][Full Text] [Related]
17. [Pulmonary MALT lymphoma revealing AIDS].
Cortot AB; Cottin V; Issartel B; Meyronet D; Coiffier B; Cordier JF
Rev Mal Respir; 2006 Sep; 23(4 Pt 1):353-7. PubMed ID: 17127912
[TBL] [Abstract][Full Text] [Related]
18. Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma.
Seker M; Bilici A; Ustaalioglu BO; Salman T; Sonmez B; Canpolat NA; Salepci T; Gumus M; Yaylaci M
Leuk Res; 2009 Sep; 33(9):e154-6. PubMed ID: 19386361
[No Abstract] [Full Text] [Related]
19. 90Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa associated lymphoid tissue lymphoma.
Hoffmann M; Troch M; Eidherr H; Traub-Weidinger T; Jonak C; Muellauer L; Raderer M
Leuk Lymphoma; 2011 Jan; 52(1):42-5. PubMed ID: 21133720
[TBL] [Abstract][Full Text] [Related]
20. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type.
Conconi A; Martinelli G; Thiéblemont C; Ferreri AJ; Devizzi L; Peccatori F; Ponzoni M; Pedrinis E; Dell'Oro S; Pruneri G; Filipazzi V; Dietrich PY; Gianni AM; Coiffier B; Cavalli F; Zucca E
Blood; 2003 Oct; 102(8):2741-5. PubMed ID: 12842999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
